AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
STAVUDINE
36 registrations across 4 African markets— 18 active
Markets with STAVUDINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| SONKE-STAVUDINE 40 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | Jun 2024 |
| SONKE-STAVUDINE 30 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | Jun 2024 |
| DYNAVIR CAPSULES 20 mg | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | suspended | Nov 2022 |
| DYNAVIR CAPSULES 30 mg | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | suspended | Nov 2022 |
| DYNAVIR CAPSULES 40 mg | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | suspended | Nov 2022 |
| DYNAVIR CAPSULES 15 mg | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | suspended | Nov 2022 |
| VARI-STAVUDINE 30 mg | 🇿🇦South Africa | Specpharm (Pty) Ltd | suspended | Nov 2022 |
| DYNAVIR POWDER FOR ORAL SOLUTION 1 mg/ml | 🇿🇦South Africa | Aurobindo Pharma (Pty) Ltd | suspended | Sept 2022 |
| STAVUDINE 30MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2014 |
| STAVUDINE 1MG/ML FOR ORAL SOLUTION FOR ORAL SOLUTION | 🇲🇼Malawi | — | expired | Jun 2012 |
| STAVUDINE 30MG CAPSULES CAPSULES | 🇲🇼Malawi | — | expired | Jun 2011 |
| AVOSTAV-30 30MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2011 |
| STAVUDINE-15 15MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2011 |
| STAVUDINE-20 20MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2011 |
| STAVIR-30 30MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2010 |
| STAVIR-40 40MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2010 |
| AVOSTAV-40 40MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2008 |
| STAVIN-30 30MG TABLET TABLET | 🇲🇼Malawi | — | expired | Feb 2004 |
| ASPEN STAVUDINE 30 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| ASPEN STAVUDINE 40 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| ASPEN STAVUDINE 15 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| ASPEN STAVUDINE 20 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| STAVIR comprimé / 40 mg | 🇸🇳Senegal | CIPLA LTD | active | — |
| STAVIR comprimé / 30 mg | 🇸🇳Senegal | CIPLA LTD | active | — |
| AVOSTAV gélule / 30 mg | 🇸🇳Senegal | RANBAXY LABORATOIRES LIMITED | active | — |
| STAVUDINE AUROBINDO gélule / 30 mg | 🇸🇳Senegal | AUROBINDO PHARMA LTD | active | — |
| STADINE gélule / 40 mg | 🇸🇳Senegal | EMCURE PHARMACEUTICALS LTD | active | — |
| ZERIT gélule / 2O mg | 🇸🇳Senegal | BRISTOL MYERS SQUIBB | active | — |
| ZERIT GELULE | 🇲🇦Morocco | — | active | — |
| STAVUDINE DE MACLEODS gélule / 30 mg | 🇸🇳Senegal | MACLEODS PHARMACEUTICALS LTD | active | — |
| AVOSTAV GELULE | 🇲🇦Morocco | — | active | — |
| ZERIT GELULE | 🇲🇦Morocco | — | active | — |
| AVOSTAV GELULE | 🇲🇦Morocco | — | active | — |
| AVOSTAV GELULE | 🇲🇦Morocco | — | active | — |
| AVOSTAV GELULE | 🇲🇦Morocco | — | active | — |
| ZERIT gélule / 40 mg | 🇸🇳Senegal | BRISTOL MYERS SQUIBB | active | — |
STAVUDINE in Africa — Regulatory Overview
STAVUDINE is registered across 4 African markets with 36 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Malawi, Senegal, Morocco. AfricaRegulatory refreshes this data daily from official government sources.
Of the 36 registrations, 18 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.